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Background
Diffusion weighted MRI (MR-DWI) is frequently used in
oncologic therapy monitoring as it is known to predict
therapy response much earlier, than measurements of
tumour size alone. In several studies the outcome of
chemotherapeutic treatment of brain, soft tissue, bone,
breast and prostate tumours was predicted by changes in
MR-DWI. Usually, follow-up studies 2 to 4 weeks after
induction of chemotherapy show an increase in the appar-
ent diffusion coefficient (ADC), predicting size changes at
the end the treatment cycle. DWI measurements in
patients with NSCLC ultra early after starting chemother-
apy are missing.
Patients & methods
23 patients with lung cancer (aged 63.6 ± 7.2 years) under-
went serial MRI before and 24h after starting platin-based
chemotherapeutical regimens. The MRI protocol con-
tained a DWI sequence with 6 b-values ranging from 0 to
800. Online calculated trace images and the apparent
diffusion coefficient (ADC) were used for response evalua-
tion. In 19 patients both clinical information and RECIST
evaluations at the end of the second chemotherapy cycle
were available.
Results
18 out of 23 patients showed a decrease in ADC maps
24h after starting treatment.
In three of the 19 patients with available follow-up data,
no initial ADC reduction was observed. In all of these
patients a progressive disease was observed by the time of
completing the second therapy cycle. In 14 patients, initial
ADC reduction was associated with tumour size reduction
at the end of the chemotherapy cycle.
Conclusion
Chemotherapy treatment of NSCLC is regularly associated
with a decrease in ADC 24h after starting chemotherapy.
Initial ADC reduction may predict morphologic tumour
response to CHT.
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